CompletedNot Applicable

Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France

France1,017 participantsStarted 2022-05-09

Plain-language summary

CAP'Hospi is an observational, multicentric study in France which primary objective is to describe the proportion of Community Acquired Pneumonia due to serotypes included in PCV20 among adults hospitalized for CAP

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults 18 years of age or older
✓. Admission to hospital for at least 24 hours
✓. Suspicion of community-acquired pneumonia at admission defined as the association of: Radiologic findings consistent with pneumonia (eg, pleural effusion, increased pulmonary density due to infection and/or alveolar infiltrates \[multilobar, lobar, or segmental\] containing air bronchograms), AND The presence of ≥2 of the following signs or symptoms: Fever (oral temperature \>38°C or tympanic temperature \>38.5°C) in the 24 hours preceding admission; Hypothermia (\<35.5°C measured by a healthcare provider) in the 24 hours preceding admission ; Chills or rigors ; Pleuritic chest pain ; New or worsening cough ; Sputum production ; Dyspnea (shortness of breath); Tachypnea (respiratory rate \>20/min) ; Malaise ; Abnormal auscultatory findings suggestive of pneumonia (rales or evidence of pulmonary consolidation)
✓. Written informed consent from the patient

Exclusion criteria

✕. Suspicion of tuberculosis
✕. Individuals placed under judicial protection
✕. Individuals who refuse the transfer of biological samples to the USA
✕. Patient developing signs and symptoms of pneumonia after having been hospitalized for 48 hours or more
✕. Pregnancy

What they're measuring

proportions of S. pneumoniae serotypes included in PCV20

Timeframe: 2 years

Trial details

NCT IDNCT05380193

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2025-02-06

View on ClinicalTrials.gov More Pneumonia trials